Monday, March 1, 2010

arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development

ROTTERDAM, The Netherlands, March 1, 2010 /PRNewswire/ --


- SIMPLE Antibody(TM) Platform Delivers Unprecedented Choice

of Ultra-Potent Functional Antibody Leads Against Challenging Soluble

and Cell Surface Targets.


- ARGX-109, a Fully Human mAb Targeting Autoimmune,

I


http://digg.com/u1OcrX

No comments:

Post a Comment